QGEN
Qiagen N.V.
NYSE · Healthcare · Medical - Diagnostics & Research · NL
$43.43
−0.98%Margins
Gross margin
61.8%
EBITDA margin
35.0%
EBIT margin
25.3%
Net margin
19.5%
FCF margin
21.3%
12.2%
Return on equity
7.0%
Return on assets
10.6%
Return on invested capital
0.36x
Asset turnover
$654.5M
Cash from operations
$3.84
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026